FDA Sets Its Sights On AI And Big Data For Medical Device Innovation
In the FDA’s annual Focus Areas of Regulatory Science report, the agency lays out its areas of interest for the use of medical device advancement in public health and the research and development of medical devices.
You may also be interested in...
The US FDA has labelled a recall of intensive care ventilators from Hamilton Recall as class I, the agency’s most serious. A hardware issue could cause the machines to shut down.
Many commenters on the US FDA’s draft Quality Management System Regulation want two or three years to comply, but one medtech expert says that length of time could put the agency in a difficult position. Our coverage of the FDA’s draft QMSR – and an array of other news and analysis – topped our list of most-read Medtech Insight stories in May.
The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.